Results 211 to 220 of about 30,778 (256)
Some of the next articles are maybe not open access.
Beta-Emitting Radionuclides for Peptide Receptor Radionuclide Therapy
Current Topics in Medicinal Chemistry, 2013The paper focuses on the β-emitting radionuclides which might be useful for peptide receptor radionuclide therapy, PRRT. For the effective design of the radiopharmaceutical, the choice of radionuclide will depend on the purpose for which the radioligand is being used and on the physicochemical properties of the radionuclide.
J L, Parus, R, Mikolajczak
openaire +2 more sources
2009
Most patients with advanced cancer develop metastatic bone disease; this untreatable evolution of the disease weights heavily on cancer-related mortality and morbidity. Although bone metastases are often clinically silent, some conditions may support bone pain.
openaire +1 more source
Most patients with advanced cancer develop metastatic bone disease; this untreatable evolution of the disease weights heavily on cancer-related mortality and morbidity. Although bone metastases are often clinically silent, some conditions may support bone pain.
openaire +1 more source
Radionuclide therapy beyond radioiodine
Wiener Medizinische Wochenschrift, 2012For decades, Iodine-131 has been used for the treatment of patients with thyroid cancer. In recent years, increasingly, other radiopharmaceuticals are in clinical use in the treatment of various malignant diseases. Although in principle these therapies-as in all applications of radionuclides-special radiation protection measures are required, a ...
openaire +2 more sources
2008
Clinical applications of targeted radionuclide treatment have evolved considerably over the last 10–20 years, principally as a result of an improved understanding of tumour biology, and the identification of biochemical pathways and protein targets expressed preferentially on tumours compared to normal tissue.
Andrew M. Scott, Sze-Ting Lee
openaire +1 more source
Clinical applications of targeted radionuclide treatment have evolved considerably over the last 10–20 years, principally as a result of an improved understanding of tumour biology, and the identification of biochemical pathways and protein targets expressed preferentially on tumours compared to normal tissue.
Andrew M. Scott, Sze-Ting Lee
openaire +1 more source
2016
Therapeutic applications of alpha (α)-emitting radionuclides were introduced soon after the isolation of radium from pitch blende by Marie Curie in the early twentieth century. Because of the very high linear energy transfer (LET), α-emitters can be very lethal and result in very effective cell killing sterilization if the α-decay commences at the ...
F. F. Knapp, Ashutosh Dash
openaire +1 more source
Therapeutic applications of alpha (α)-emitting radionuclides were introduced soon after the isolation of radium from pitch blende by Marie Curie in the early twentieth century. Because of the very high linear energy transfer (LET), α-emitters can be very lethal and result in very effective cell killing sterilization if the α-decay commences at the ...
F. F. Knapp, Ashutosh Dash
openaire +1 more source
American Journal of Clinical Oncology, 1989
This book presents a survey of uses of parenterally administered radionuclides as therapeutic sources and concentrates on both the basic considerations of each mode of use as well as the clinical results and experiences. This volume provides a source of information for the clinical physician and scientist involved in therapy, and describes current ...
openaire +1 more source
This book presents a survey of uses of parenterally administered radionuclides as therapeutic sources and concentrates on both the basic considerations of each mode of use as well as the clinical results and experiences. This volume provides a source of information for the clinical physician and scientist involved in therapy, and describes current ...
openaire +1 more source
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians, 2021Kyle Wang
exaly